145 related articles for article (PubMed ID: 28538836)
1. Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsy.
Zhuang YP; Zhu YP; Wang HY; Sun L; Zhang J; Hao YP; Wang L
Braz J Med Biol Res; 2017 May; 50(6):e6000. PubMed ID: 28538836
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a non-small-cell lung cancer-liver metastasis patient-derived tumor xenograft model for the evaluation of patient-tailored chemotherapy.
Yang X; Meng G
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221816
[TBL] [Abstract][Full Text] [Related]
3. Establishment of the PDTX model of gynecological tumors.
Yang W; Fan WS; Ye MX; Li Z; Gu CL; Zhu YP; Hao YP; Wang ZQ; Wang L; Meng YG
Am J Transl Res; 2019; 11(6):3779-3789. PubMed ID: 31312388
[TBL] [Abstract][Full Text] [Related]
4. A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).
Cheng Y; Qin SK; Li J; Dai GH; Shen BY; Ying JE; Ba Y; Liang H; Wang XB; Xu Y; Zhou L; Ding KF; Qin YR; Yang SJ; Guan WX; Zheng H; Wang Q; Song H; Zhu YP
J Cancer Res Clin Oncol; 2022 Mar; 148(3):673-684. PubMed ID: 33864522
[TBL] [Abstract][Full Text] [Related]
5. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.
Fichtner I; Rolff J; Soong R; Hoffmann J; Hammer S; Sommer A; Becker M; Merk J
Clin Cancer Res; 2008 Oct; 14(20):6456-68. PubMed ID: 18927285
[TBL] [Abstract][Full Text] [Related]
6. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
Hall JC; Marlow LA; Mathias AC; Dawson LK; Durham WF; Meshaw KA; Mullin RJ; Synnott AJ; Small DL; Krishna M; von Hoff D; Schüler J; Hart SN; Couch FJ; Colon-Otero G; Copland JA
J Transl Med; 2016 May; 14(1):129. PubMed ID: 27165126
[TBL] [Abstract][Full Text] [Related]
7. A Preliminary Study on the Establishment of the PDTX Model.
Liu Y; Zhu YP; Cai MZ; Ke B; Li B; Liu N; Xue Q; Zhan HJ; Deng JY; Zhang L; Hao YP; Wang ZQ; Wang L; Liang H
Cancer Manag Res; 2020; 12():1969-1979. PubMed ID: 32256107
[TBL] [Abstract][Full Text] [Related]
8. [Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer].
Qin B; Jiao X; Yuan L; Liu K; Zang Y
Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):715-719. PubMed ID: 29061220
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer.
Zhu Y; Tian T; Li Z; Tang Z; Wang L; Wu J; Li Y; Dong B; Li Y; Li N; Zou J; Gao J; Shen L
Sci Rep; 2015 Feb; 5():8542. PubMed ID: 25712750
[TBL] [Abstract][Full Text] [Related]
10. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
[TBL] [Abstract][Full Text] [Related]
11. A patient-derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma.
Yamano T; Kubo S; Tomita N
Cancer Med; 2020 May; 9(10):3337-3343. PubMed ID: 32168428
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous CT-guided biopsy of lytic bone lesions in patients clinically suspected of lung cancer: Diagnostic performances for pathological diagnosis and molecular testing.
Toffart AC; Asfari S; Mc Leer A; Reymond E; Jankowski A; Moro-Sibilot D; Stephanov O; Ghelfi J; Lantuejoul S; Ferretti GR
Lung Cancer; 2020 Feb; 140():93-98. PubMed ID: 31901769
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy.
Dong X; Guan J; English JC; Flint J; Yee J; Evans K; Murray N; Macaulay C; Ng RT; Gout PW; Lam WL; Laskin J; Ling V; Lam S; Wang Y
Clin Cancer Res; 2010 Mar; 16(5):1442-51. PubMed ID: 20179238
[TBL] [Abstract][Full Text] [Related]
14. Successful establishment of patient-derived tumor xenografts from gastrointestinal stromal tumor-a single center experience.
Jiang Q; Tong HX; Zhang Y; Hou YY; Li JL; Wang JY; Zhou YH; Lu WQ
Am J Cancer Res; 2016; 6(2):533-43. PubMed ID: 27186422
[TBL] [Abstract][Full Text] [Related]
15. [Establishment and its biological characteristics of patient-derived lung cancer xenograft models].
Zhuo Y; Wu Y; Guo A; Chen S; Su J
Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):568-74. PubMed ID: 20681441
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience.
Belfiore MP; Ronza FM; Romano F; Ianniello GP; De Lucia G; Gallo C; Marsicano C; Di Gennaro TL; Belfiore G
Int J Surg; 2015 Sep; 21 Suppl 1():S34-9. PubMed ID: 26118600
[TBL] [Abstract][Full Text] [Related]
17. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
18. A novel AKR1C3 specific prodrug AST-3424 and its combination therapy in hepatocellular carcinoma.
Xun C; Zhang Y; Zheng X; Qin S
J Pharmacol Sci; 2023 Jun; 152(2):69-75. PubMed ID: 37169481
[TBL] [Abstract][Full Text] [Related]
19. A bioengineered metastatic pancreatic tumor model for mechanistic investigation of chemotherapeutic drugs.
Wang X; Zhang X; Fu Z; Yin H
J Biotechnol; 2013 Jul; 166(4):166-73. PubMed ID: 23747489
[TBL] [Abstract][Full Text] [Related]
20. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model.
Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS
Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
